$JAGX News

Jaguar Health Registers $75M Of Securities Under Form S-3

Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder

Jaguar Health's Napo Pharma Announces Expanded-Access Benefit Of Crofelemer In Congenital Sodium Diarrhea Patient; Plans To File NDA For Crofelemer For MVID In Mid-2027

Jaguar Health Provides Update Regarding Special Stock Dividend

Jaguar Health Provides Update On Special Stock Dividend; Nasdaq Sets October 16 Ex-Dividend Date

Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer

Jaguar Health Demonstrates Recap Of Preliminary Data At American College Of Gastroenterology Annual Scientific Meeting For Its Current Trial Of Crofelemer Powder For Oral Solution In Adult Patients With Type 1 Short Bowel Syndrome With Intestinal Failure

Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

Jaguar Health Targets Mid-2027 MVID NDA Filing as Crofelemer Intestinal Failure Program Advances

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi

Jaguar Health (JAGX) Stock Climbs Over 34% After-Hours: What's Going On?

Jaguar Health Announces a Special Stock Dividend

Napo Pharmaceuticals Crofelemer Study Accepted for Presentation at ACG 2026

Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split Float

Jaguar Health Stock Surges Friday: What's Happening?

Jaguar Health Announces Issuance Of 182,091 Shares To Streeterville Capital For $1.67832M Reduction In 2021 Note Balance; 2025 Streeterville Note Fully Paid And Cancelled Following Exchange For 547,898 Shares

Jaguar Health Stock Slides Thursday: What's Happening?

Reported Earlier: Jaguar Health Issues 547,898 Common Shares To Streeterville Capital To Retire ~$5.05M Of Outstanding Promissory Note

Jaguar Health Files Supplement To Offer Up To ~$9.82M Of Common Stock Under At-The-Market Offering Program